ABSTRACT
Rosuvastatin calcium is a synthetic lipid lowering agent which is used in hypercholesterolemia. It is a selective and competitive inhibitor of HMG-CoA reductase. In this study a simple, rapid and reliable spectrophotometric method was developed for the determination of rosuvastatin calcium in pharmaceutical preparations. The solutions of standard and pharmaceutical samples were prepared in methanol. 243 nm was chosen for measuring absorbances of rosuvastatin calcium. The developed method was validated with respect to linearity range, limit of detection and quantitation, accuracy, precision, specificity and ruggudness. The linearity range of the method was 1.0-60.0 microg mL(-1). The limit of detection was 0.33 microg mL(-1). The developed and validated method was applied to the determination of rosuvastatin calcium in pharmaceutical preparations.
Subject(s)
Fluorobenzenes/analysis , Hydroxymethylglutaryl-CoA Reductase Inhibitors/analysis , Pyrimidines/analysis , Sulfonamides/analysis , Calibration , Indicators and Reagents , Reference Standards , Reproducibility of Results , Rosuvastatin Calcium , Spectrophotometry, Ultraviolet , TabletsABSTRACT
A simple, rapid and reliable UV spectrophotometric method was developed for the determination of olmesartan medoxomil in pharmaceutical dosage forms. The solutions of standard, tablet and synthetic tablet were prepared in acetonitrile and in NaOH-Water. 258 nm and 250 nm were chosen for acetonitrile and for NaOH-Water solutions respectively. The developed method was validated with respect to stability, linearity, sensitivity, specificity, precision, accuracy, robustness and ruggedness. The linearity range of the method was 1.0-70.0 microg x mL(-1) for acetonitrile solutions and 1.0-75.0 microg x mL(-1) for NaOH-Water solutions. The developed and validated method was applied for the determination of olmesartan medoxomil in pharmaceutical dosage forms.
Subject(s)
Angiotensin II Type 1 Receptor Blockers/analysis , Imidazoles/analysis , Tetrazoles/analysis , Acetonitriles , Olmesartan Medoxomil , Reference Standards , Reproducibility of Results , Sodium Hydroxide , Solutions , Solvents , Spectrophotometry, Ultraviolet , TabletsABSTRACT
An efficient and reliable micellar electrokinetic capillary chromatography (MEKC) method has been developed for the simultaneous determination of isoniazid (ISO) and pyridoxine hydrochloride (PYR) in pharmaceutical formulations. A chemometric two level full factorial design approach was used to search for the optimum conditions of separation. Three parameters were selected for this study: the buffer pH, the buffer concentration and sodium dodecyl sulphate (SDS) concentrations. Resolution, peak symmetry and analysis time were established as response. The two analytes were separated within 6 min with the optimized conditions: 50 mM borate buffer, 25 mM SDS pH 7.8, 35 degrees C, at 50 mbar 4s injection and 30 kV by using a fused silica capillary (72 cm effective length, 50 microm i.d.). The detection wavelength was set to 205 nm. Meloxicam was used as internal standard. The method was validated with respect to stability, linearity range, limit of quantitation and detection, precision, accuracy, specificity and robustness. The detection limits of the method were 1.0 microg mL(-1) for ISO and 0.40 microg mL(-1) for PYR and the method was linear at least in the range of 3.0-100 microg mL(-1) for ISO and 1.0-100 microg mL(-1) for PYR with excellent correlation coefficients (0.9995 for ISO and 0.9998 for PYR). Relative standard deviations (R.S.D.s) of the described method ranged between 0.54 and 2.27% for intra-day precision and between 0.65 and 2.69% for inter-day precision. The developed method was applied to the tablet form of ISO and PYR-containing the pharmaceutical preparations and the data were compared with obtained from the standard addition method. No statistically significant difference was found.
